September 2016

Glen Weiss, MD, MBA, was named 2016 Healthcare Leadership Awards’ Researcher of the Year by AZ Business magazine. Dr. Weiss is Director of Clinical Research, Director of Phase I and II […]

David Spigel has been appointed chief scientific officer of Sarah Cannon Research Institute, Nashville, US, and will oversee the development and operations of Sarah Cannon’s clinical research program. Dr. Spigel joined […]

Mark A. Socinski has been appointed Executive Medical Director of the Florida Hospital Cancer Institute, and will oversee the coordination of clinical cancer services for the Florida Hospital network. He will […]

David H. Johnson received the 2016 ASCO Distinguished Achievement Award, which is given annually and recognizes leadership or mentorship by a scientist, practitioner, or researcher who has benefited patients with cancer […]

Jeffrey Engelman has been appointed Vice President and Global Head of Oncology at the Novartis Institutes of BioMedical Research. Prior to joining Novartis, Dr. Engelman was Director of the Center for […]

Laurie Fenton Ambrose received the 2016 James L. Mulshine, MD Leadership Award, which recognized her efforts in guiding patient advocacy and other stakeholder groups in the successful efforts to gain […]

Jean-Marie Cuillerot has been appointed Vice President and Global Head of Clinical Development at Agenus, Inc, Lexington, US, overseeing ongoing clinical development of checkpoint targeted antibodies, including AGEN1884 targeting CTLA-4 and […]

Anton Berns was elected to the National Academy of Sciences (NAS). NAS membership is in recognition of distinguished and continuing achievements in original research. Dr. Berns is the Senior Group Leader […]